Detalhe da pesquisa
1.
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial.
Clin Gastroenterol Hepatol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729400
2.
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study.
Am J Gastroenterol
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38275272
3.
Tryptophan Metabolism 'Hub' Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease.
Int J Mol Sci
; 23(23)2022 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499104
4.
High prevalence of Crohn disease and ulcerative colitis among older people in Sydney.
Med J Aust
; 214(8): 365-370, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502004
5.
Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease.
Mol Cell Proteomics
; 16(7): 1244-1257, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490445
6.
Combination Therapy of Immunomodulators With Non-Anti-Tumor Necrosis Factor Agents in Inflammatory Bowel Disease: Need More Evidence?
Clin Gastroenterol Hepatol
; 20(3): e640-e641, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34044129
7.
Cryptococcal osteomyelitis of the skull in a liver transplant patient.
Transpl Infect Dis
; 18(6): 954-956, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601128
8.
Safety comparison of therapies used in inflammatory bowel disease.
J Gastroenterol Hepatol
; 36 Suppl 1: 20-21, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33817854
9.
Meta-analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease.
Aliment Pharmacol Ther
; 59(11): 1312-1334, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651771
10.
Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol.
BMJ Open
; 13(10): e073071, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788929
11.
Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists.
World J Gastroenterol
; 29(2): 378-389, 2023 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36687119
12.
Vedolizumab has longer persistence than infliximab as a first-line biological agent but not as a second-line biological agent in moderate-to-severe ulcerative colitis: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study.
Therap Adv Gastroenterol
; 15: 17562848221080793, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35282607
13.
Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey.
Eur J Gastroenterol Hepatol
; 32(8): 976-983, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32453008
14.
Safety of drugs used for the treatment of Crohn's disease.
Expert Opin Drug Saf
; 18(5): 357-367, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31026401
15.
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply.
Aliment Pharmacol Ther
; 60(1): 103-104, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779926
16.
Duodenal obstruction from a secondary aortoduodenal fistula.
ANZ J Surg
; 86(7-8): 616-7, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24975196